426
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Research

Induction of p53 suppresses chronic myeloid leukemia

, , , , , , , , & show all
Pages 2165-2175 | Received 08 Aug 2016, Accepted 10 Dec 2016, Published online: 13 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vasco F. Batista, Diana C. G. A. Pinto & Artur M. S. Silva. (2022) Recent in vivo advances of spirocyclic scaffolds for drug discovery. Expert Opinion on Drug Discovery 17:6, pages 603-618.
Read now

Articles from other publishers (7)

Na Liu, Rui Ling, Xiang Tang, Yunpeng Yu, Yuepeng Zhou & Deyu Chen. (2022) Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor. Frontiers in Oncology 12.
Crossref
Hanieh Mojtahedi, Niloufar Yazdanpanah & Nima Rezaei. (2021) Chronic myeloid leukemia stem cells: targeting therapeutic implications. Stem Cell Research & Therapy 12:1.
Crossref
Yammy Yung, Emily Lee, Hiu-Tung Chu, Pui-Kwan Yip & Harinder Gill. (2021) Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms. International Journal of Molecular Sciences 22:2, pages 659.
Crossref
Daniela S. Krause. (2019) Killing the minotaur in its amazing maze. Blood 134:22, pages 1884-1885.
Crossref
Giovanna Carrà, Isabella Russo, Angelo Guerrasio & Alessandro Morotti. (2019) Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy. Cells 8:10, pages 1248.
Crossref
Hayder Al-kuraishy, Ali Al-Gareeb & Ali Al-Buhadilly. (2018) p53 Gene (NY-CO-13) Levels in Patients with Chronic Myeloid Leukemia: The Role of Imatinib and Nilotinib. Diseases 6:1, pages 13.
Crossref
Ravi Bhatia. (2017) Novel approaches to therapy in CML. Hematology 2017:1, pages 115-120.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.